2024
Isoelectric focusing followed by affinity immunoblotting to detect monoclonal free light chains in monoclonal gammopathies: Comparison with immunofixation electrophoresis and free light chain ratio
ZEMAN, David, Martin ŠTORK, Lenka ŠVANCAROVÁ, Marek BORSKÝ, Michaela POSPÍŠILOVÁ et. al.Základní údaje
Originální název
Isoelectric focusing followed by affinity immunoblotting to detect monoclonal free light chains in monoclonal gammopathies: Comparison with immunofixation electrophoresis and free light chain ratio
Autoři
ZEMAN, David (203 Česká republika, domácí), Martin ŠTORK (203 Česká republika, domácí), Lenka ŠVANCAROVÁ (203 Česká republika, domácí), Marek BORSKÝ (203 Česká republika, domácí), Michaela POSPÍŠILOVÁ (203 Česká republika, domácí), Zdeněk ADAM (203 Česká republika, domácí), Miroslava BEŇOVSKÁ (203 Česká republika, domácí) a Luděk POUR (203 Česká republika, domácí)
Vydání
Annals of Clinical Biochemistry, THOUSAND OAKS, SAGE PUBLICATIONS INC, 2024, 0004-5632
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
20602 Medical laboratory technology ;
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 2.200 v roce 2022
Organizační jednotka
Lékařská fakulta
UT WoS
001158687400001
Klíčová slova anglicky
Isoelectric focusing; immunoblotting; immunofixation; free light chains; AL amyloidosis; multiple myeloma; minimal residual disease
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 5. 11. 2024 15:00, Mgr. Tereza Miškechová
Anotace
V originále
Background: Isoelectric focusing (IEF) is a method with an exquisite resolution, and coupled with affinity immunoblotting (AIB), it can provide superior sensitivity to detect monoclonal free light chains (FLC). Methods: We tested the hypothesis that IEF/AIB is more sensitive and specific for monoclonal FLC detection in serum and urine samples than conventional methods, that is, electrophoresis (ELP), immunofixation (IF) and serum FLC ratio assessment. Investigation included 107 samples of 68 patients, among which 21 multiple myeloma patients were recently tested for minimal residual disease and 18 patients with AL amyloidosis. Results: Monoclonal FLC were detected by IEF/AIB in 37% of serum samples negative for monoclonal FLC on ELP/IF. As for urine samples, significant advantage of the IEF/AIB over ELP/IF was not demonstrated. Considering both serum and urine results, IEF/AIB definitely revealed monoclonal FLC in 20/83 (24%) of ELP/IF-negative samples. FLC ratio was abnormally high (>1.65) in all 11 patients definitely positive for monoclonal FLC kappa by IEF/AIB but also in 16/47 (34%) IEF/AIB-negative samples. Abnormally low values (<0.26) were found only in 10/28 samples (36%) positive for monoclonal FLC lambda. Appropriate use of renal FLC ratio reference range reduced the number of presumably false positives (6/47, i.e. 13%) but not false negatives (17/28, i.e. 61%). Conclusions: The IEF/AIB method is more sensitive than IF and might be used in patients with negative IF results before deciding whether to proceed to minimal residual disease testing.